Search

everythinglearnresearchcommunity

for

Search:↓

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

A new therapy for a skin blistering condition has not been developed yet.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.